Guardion Health Sciences, Inc. (GHSI)
NASDAQ: GHSI · IEX Real-Time Price · USD
8.07
+0.07 (0.88%)
At close: May 3, 2024, 3:59 PM
7.97
-0.10 (-1.24%)
After-hours: May 3, 2024, 6:08 PM EDT

Guardion Health Sciences Revenue

In the year 2023, Guardion Health Sciences had annual revenue of $12.25M with 10.85% growth. Revenue in the quarter ending December 31, 2023 was $2.94M with 7.68% year-over-year growth.

Revenue (ttm)
$12.25M
Revenue Growth
+10.85%
P/S Ratio
0.85
Revenue / Employee
$1,360,950
Employees
9
Market Cap
10.27M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202312.25M1.20M10.85%
Dec 31, 202211.05M3.82M52.77%
Dec 31, 20217.23M5.34M282.74%
Dec 31, 20201.89M986.91K109.30%
Dec 31, 2019902.94K-39.22K-4.16%
Dec 31, 2018942.15K504.80K115.42%
Dec 31, 2017437.35K296.32K210.11%
Dec 31, 2016141.03K28.22K25.01%
Dec 31, 2015112.81K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Biofrontera 34.07M
Genetic Technologies 5.78M
Biomerica 5.41M
Aeterna Zentaris 4.50M
BioCardia 477.00K
Organovo Holdings 242.00K
China SXT Pharmaceuticals 29.92K
Bionomics 15.00K
Revenue Rankings